Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kosmidis, PA
Kalofonos, C
Syrigos, K
Skarlos, D
Fountzilas, G
Nicolaides, C
Bafaloukos, D
Samantas, E
Bakogiannis, C
Dimopoulos, AM
机构：
[1] Hygeia Hosp, Athens, Greece
[2] Hosp Patra, Patras, Greece
[3] SOTIRIA Hosp, Athens, Greece
[4] Errikos Dunan Hosp, Athens, Greece
[5] Ahepa Hosp, Thessaloniki, Greece
[6] Ioannina Hosp, Ioannina, Greece
[7] Metropolitan Hosp, Piraeus, Greece
[8] Agioi Anargyroi Hosp, Athens, Greece
[9] Alexandra Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：621S / 621S
页数：1
相关论文
共 50 条
  • [21] Triplet chemotherapy with paclitaxel, gemcitabine and carboplatin in advanced non-small cell lung cancer
    Bunn, PA
    Kelly, K
    Mikhaeel, N
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 21 - 21
  • [22] Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer
    Comella, P
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 7 - 10
  • [23] Paclitaxel and Carboplatin in combination with Gemcitabine (PCG): A phase I-II trial in non-small cell lung cancer (NSCLC)
    Favaretto, A
    Paccagnella, A
    Tumolo, S
    Barbieri, F
    Ceresoli, G
    Gulisano, M
    Oniga, F
    Bearz, A
    Fiorentino, MV
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [24] Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
    Masotti, A
    Zannini, G
    Gentile, A
    Morandini, G
    LUNG CANCER, 2002, 36 (01) : 99 - 103
  • [25] Multicenter phase H trial of biweekly carboplatin and gemcitabine for untreated advanced non-small-cell lung cancer (NSCLC)
    Dómine, M
    Gómez, RG
    Firvida, JL
    Delgado, JR
    Estévez, LG
    León, A
    Casado, V
    Alvarez, R
    Alfonso, AL
    Lobo, F
    ANNALS OF ONCOLOGY, 2005, 16 : 308 - 308
  • [26] Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Zatloukal, P
    Petruzelka, L
    LUNG CANCER, 2002, 38 : S33 - S36
  • [27] Gemcitabine versus gemcitabine/carboplatin in advanced non-small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group
    Sederholm, C
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 50 - 54
  • [28] A multicenter phase II study of induction chemotherapy with gemcitabine and carboplatin in locally advanced non-small cell lung cancer (NSCLC)
    Aerts, Joachim G.
    van Klaveren, Rob J.
    Surmont, Veerle
    Senan, Suresh
    Tan, Yoeke
    Vernhout, Rene
    van Wijhe, Gerda
    Verhoeven, Gert T.
    Hoogsteden, Henk C.
    van Meerbeeck, Jan P.
    ANNALS OF ONCOLOGY, 2004, 15 : 174 - 175
  • [29] Randomized phase II trial of the biweekly schedule of adjuvant chemotherapy with carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with non-small cell lung cancer (NSCLC)
    Sugio, K.
    Nagashima, A.
    Nakanishi, R.
    Uchiyama, A.
    Inoue, M.
    Osaki, T.
    Yoshimatsu, T.
    Takenoyama, M.
    Hanagiri, T.
    Yasumoto, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
12345